Biophysical Characterization of CD6—TCR/CD3 Interplay in T Cells
暂无分享,去创建一个
C. Figdor | A. Cambi | J. Kanger | R. Brock | M. Meddens | J. te Riet | Svenja F B Mennens | J. Witsenburg | F. Celikkol | B. Joosten | Svenja F. B. Mennens | Carl G. Figdor | F. Burcu Celikkol
[1] D. Fox,et al. Clinical and experimental evidence for targeting CD6 in immune-based disorders. , 2018, Autoimmunity reviews.
[2] A. Weiss,et al. TCR Signaling: Mechanisms of Initiation and Propagation. , 2017, Trends in biochemical sciences.
[3] M. Moasser,et al. CD318 is a ligand for CD6 , 2017, Proceedings of the National Academy of Sciences.
[4] David J. Williamson,et al. Live-Cell Super-resolution Reveals F-Actin and Plasma Membrane Dynamics at the T Cell Synapse. , 2017, Biophysical journal.
[5] D. Fox,et al. CD6 as a potential target for treating multiple sclerosis , 2017, Proceedings of the National Academy of Sciences.
[6] A. Spurkland,et al. CD6 and Linker of Activated T Cells are Potential Interaction Partners for T Cell‐Specific Adaptor Protein , 2017, Scandinavian journal of immunology.
[7] S. Dogra,et al. Itolizumab, a novel anti-CD6 monoclonal antibody: a safe and efficacious biologic agent for management of psoriasis , 2017, Expert opinion on biological therapy.
[8] Takashi Saito,et al. Dynamic Regulation of TCR–Microclusters and the Microsynapse for T Cell Activation , 2016, Front. Immunol..
[9] Liliana Oliveira,et al. Tuning T Cell Activation: The Function of CD6 At the Immunological Synapse and in T Cell Responses. , 2016, Current drug targets.
[10] L. Aira,et al. Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab. , 2016, Current drug targets.
[11] L. Aira,et al. Immunological evaluation of rheumatoid arthritis patients treated with itolizumab , 2016, mAbs.
[12] Alexandra Moreira,et al. T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1 , 2014, The Journal of Immunology.
[13] H. Lähdesmäki,et al. Quantitative proteomics analysis of signalosome dynamics in primary T cells identifies the surface receptor CD6 as a Lat adaptor–independent TCR signaling hub , 2014, Nature Immunology.
[14] R. Zamoyska,et al. T cell receptor signalling networks: branched, diversified and bounded , 2013, Nature Reviews Immunology.
[15] Jay T. Groves,et al. Modulation of T cell signaling by the actin cytoskeleton , 2013, Journal of Cell Science.
[16] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[17] M. Yáñez-Mó,et al. Association of syntenin-1 with M-RIP polarizes Rac-1 activation during chemotaxis and immune interactions , 2012, Journal of Cell Science.
[18] J. Hammer,et al. Actin retrograde flow and actomyosin II arc contraction drive receptor cluster dynamics at the immunological synapse in Jurkat T cells , 2012, Molecular biology of the cell.
[19] S. Davis,et al. CD6 attenuates early and late signaling events, setting thresholds for T-cell activation , 2011, European journal of immunology.
[20] R. Díez-Ahedo,et al. Geometry sensing by dendritic cells dictates spatial organization and PGE2-induced dissolution of podosomes , 2011, Cellular and Molecular Life Sciences.
[21] Suliana Manley,et al. Functional nanoscale organization of signaling molecules downstream of the T cell antigen receptor. , 2011, Immunity.
[22] J. Ellwart,et al. The CD6 Scavenger Receptor Is Differentially Expressed on a CD56dim Natural Killer Cell Subpopulation and Contributes to Natural Killer-Derived Cytokine and Chemokine Secretion , 2010, Journal of Innate Immunity.
[23] Arup K Chakraborty,et al. Understanding the Structure and Function of the Immunological Synapse , 2010 .
[24] Vinod Subramaniam,et al. Spatially resolved local intracellular chemical sensing using magnetic particles , 2010 .
[25] Michael Loran Dustin,et al. Functional anatomy of T cell activation and synapse formation. , 2010, Annual review of immunology.
[26] P. Nazarov,et al. A mathematical model of actin filament turnover for fitting FRAP data , 2010, European Biophysics Journal.
[27] Ludwig Kappos,et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci , 2009, Nature Genetics.
[28] Gerhard J Schütz,et al. Micropatterning for quantitative analysis of protein-protein interactions in living cells , 2008, Nature Methods.
[29] A. Chakraborty,et al. The balance between T cell receptor signaling and degradation at the center of the immunological synapse is determined by antigen quality. , 2008, Immunity.
[30] T. Holak,et al. Lifeact: a versatile marker to visualize F-actin , 2008, Nature Methods.
[31] Rajat Varma,et al. Mechanisms for segregating T cell receptor and adhesion molecules during immunological synapse formation in Jurkat T cells , 2007, Proceedings of the National Academy of Sciences.
[32] F. Cordelières,et al. A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.
[33] A. Barclay,et al. CD6 Regulates T-Cell Responses through Activation-Dependent Recruitment of the Positive Regulator SLP-76 , 2006, Molecular and Cellular Biology.
[34] Rajat Varma,et al. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. , 2006, Immunity.
[35] C. Figdor,et al. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells. , 2006, Blood.
[36] Takashi Saito,et al. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76 , 2005, Nature Immunology.
[37] Rajat Varma,et al. Actin and agonist MHC–peptide complex–dependent T cell receptor microclusters as scaffolds for signaling , 2005, The Journal of experimental medicine.
[38] C. Serra-Pages,et al. The Lymphocyte Receptor CD6 Interacts with Syntenin-1, a Scaffolding Protein Containing PDZ Domains 1 , 2005, The Journal of Immunology.
[39] V. Barr,et al. Dynamic molecular interactions linking the T cell antigen receptor to the actin cytoskeleton , 2005, Nature Immunology.
[40] M. Saifullah,et al. Expression and Characterization of a Novel CD6 Ligand in Cells Derived from Joint and Epithelial Tissues1 , 2004, The Journal of Immunology.
[41] F. Sánchez‐Madrid,et al. Relevance of CD6-Mediated Interactions in T Cell Activation and Proliferation1 , 2004, The Journal of Immunology.
[42] A. Barclay,et al. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166 , 2004, European journal of immunology.
[43] Tom Misteli,et al. Measurement of dynamic protein binding to chromatin in vivo, using photobleaching microscopy. , 2004, Methods in enzymology.
[44] J. Groves,et al. Supported planar bilayers in studies on immune cell adhesion and communication. , 2003, Journal of immunological methods.
[45] F. Sánchez‐Madrid,et al. The Accessory Molecules CD5 and CD6 Associate on the Membrane of Lymphoid T Cells* , 2003, The Journal of Biological Chemistry.
[46] Alexandra Moreira,et al. OX52 is the rat homologue of CD6: evidence for an effector function in the regulation of CD5 phosphorylation , 2003, Journal of leukocyte biology.
[47] G. Schieven,et al. Tyrosine Phosphorylation of CD 6 by Stimulation of CD 3 : Augmentation by the CD 4 and CD 2 Coreceptors , 2003 .
[48] Tetsuo Yamazaki,et al. T cell receptor ligation induces the formation of dynamically regulated signaling assemblies , 2002, The Journal of cell biology.
[49] T. Salditt,et al. Preparation of Solid-Supported Lipid Bilayers by Spin-Coating , 2002 .
[50] L. Samelson,et al. Dynamic actin polymerization drives T cell receptor-induced spreading: a role for the signal transduction adaptor LAT. , 2001, Immunity.
[51] G. Reekmans,et al. Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments. , 2001, Molecular biology of the cell.
[52] S. Bromley,et al. The immunological synapse: a molecular machine controlling T cell activation. , 1999, Science.
[53] Colin R. F. Monks,et al. Three-dimensional segregation of supramolecular activation clusters in T cells , 1998, Nature.
[54] Chow,et al. Simultaneous cross‐linking of CD6 and CD28 induces cell proliferation in resting T cells , 1998, Immunology.
[55] Howard J. Worman,et al. Nuclear Membrane Dynamics and Reassembly in Living Cells: Targeting of an Inner Nuclear Membrane Protein in Interphase and Mitosis , 1997, The Journal of cell biology.
[56] N. Nowak,et al. Structure and chromosomal location of the human CD6 gene: detection of five human CD6 isoforms. , 1997, Journal of immunology.
[57] S. Chow,et al. Evidence for protein tyrosine kinase involvement in CD6-induced T cell proliferation. , 1995, Cellular immunology.
[58] W. Robinson,et al. Human CD6 possesses a large, alternatively spliced cytoplasmic domain , 1995, European journal of immunology.
[59] K. Rajewsky,et al. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. , 1995, Science.
[60] B. Haynes,et al. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand , 1995, The Journal of experimental medicine.
[61] B. Haynes,et al. Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells , 1995, The Journal of experimental medicine.
[62] S. Chow,et al. The anti-CD6 mAb, IOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation. , 1994, Cellular immunology.
[63] G. Schieven,et al. Tyrosine phosphorylation of CD6 by stimulation of CD3: augmentation by the CD4 and CD2 coreceptors , 1993, The Journal of experimental medicine.
[64] P. Linsley,et al. The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins , 1991, The Journal of experimental medicine.
[65] B. Seed,et al. Expression of the CD6 T lymphocyte differentiation antigen in normal human brain , 1990, Journal of Neuroimmunology.
[66] C. Morimoto,et al. Structural characterization of CD6: properties of two distinct epitopes involved in T cell activation. , 1989, Molecular immunology.
[67] J. Swack,et al. Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes. , 1989, Journal of immunology.
[68] W. Webb,et al. Mobility measurement by analysis of fluorescence photobleaching recovery kinetics. , 1976, Biophysical journal.